Conference - Boston, MA, United States
We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA.
With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics.
With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
Organization: GTCbio (http://www.gtcbio.com)
For more information, please visit: https://www.gtcbio.com/conferences/antibody-drug-conjugates-overview
October 22-23, 2015
Hyatt Boston Harbor, 101 Harborside Drive
Boston, MA 02128
Boston, MA 02128
Contact: Kristen Starkey (infogtcbio@gtcbio.com)
Phone: 626-256-6405
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
